Keros Therapeutics (KROS) EPS (Basic) (2019 - 2025)
Keros Therapeutics (KROS) posted EPS (Basic) of -$0.63 for Q4 2025, down 251.72% on a QoQ basis from -$0.18 in Q3 2025, and up 48.73% year-over-year from -$0.42 in Q4 2024.
Keros Therapeutics (KROS) EPS (Basic) (2019 - 2025) Analysis & Trends
Keros Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.63 for Q4 2025.
- Quarterly EPS (Basic) rose 48.73% year-over-year to -$0.63 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.34 (up 146.71% YoY) and the FY2025 annual result came in at $2.34, up 146.71% from the prior year.
- EPS (Basic) was -$0.63 for Q4 2025 at Keros Therapeutics, down from -$0.18 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.66 in Q1 2025 and bottomed at -$1.41 in Q3 2024.
- A 5-year average of -$0.75 and a median of -$1.07 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 295.86% — and 2025, when it soared 402.95%.
- Keros Therapeutics' EPS (Basic) stood at -$0.3 in 2021, then plunged by 295.86% to -$1.18 in 2022, then decreased by 16.07% to -$1.37 in 2023, then increased by 10.04% to -$1.23 in 2024, then soared by 48.73% to -$0.63 in 2025.
- Business Quant data shows KROS's EPS (Basic) at -$0.63 in Q4 2025, -$0.18 in Q3 2025, and -$0.76 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Keros Therapeutics | 374.82 Mn | 87.42 Mn | - | -0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.63 |
| Sep 30, 2025 | -0.18 |
| Jun 30, 2025 | -0.76 |
| Mar 31, 2025 | 3.66 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | -1.25 |
| Mar 31, 2024 | -1.21 |
| Dec 31, 2023 | -1.37 |
| Sep 30, 2023 | -1.33 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -1.26 |
| Dec 31, 2022 | -1.18 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -1.13 |
| Mar 31, 2022 | -1.01 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | -0.87 |
| Jun 30, 2021 | -0.67 |
| Mar 31, 2021 | -0.68 |